These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 16884993

  • 1. Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients.
    van de Garde EM, Bras LJ, Heijmen RH, Knibbe CA, van Dongen EP, Wiltink EH, Biesma DH.
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):573-5. PubMed ID: 16884993
    [No Abstract] [Full Text] [Related]

  • 2. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
    Al-Ruzzeh S, Mahmoud A, Shah S, O'Regan D.
    Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients.
    Lee AI, Campigotto F, Rawn JD, Neuberg D, Kaufman RM, Berliner N.
    Br J Haematol; 2012 May; 157(3):397-400. PubMed ID: 22224596
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
    Aguilar C, Lucía JF.
    Am J Hematol; 2007 Mar; 82(3):246-7. PubMed ID: 16924645
    [No Abstract] [Full Text] [Related]

  • 8. [Application of recombinant activated factor VII in gynecological intervention (case report)].
    Nacheva A, Gateva Zh, Atanasova V.
    Akush Ginekol (Sofiia); 2004 Mar; 43 Suppl 4():3-5. PubMed ID: 15673003
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
    Hirasaki Y, Suematsu Y, Yasuda T, Tajima K.
    Anesth Analg; 2010 Jan 01; 110(1):261-2. PubMed ID: 20023190
    [No Abstract] [Full Text] [Related]

  • 11. Invited commentary.
    Welsby IJ, Ortel TL.
    Ann Thorac Surg; 2007 Jul 01; 84(1):168-9. PubMed ID: 17588405
    [No Abstract] [Full Text] [Related]

  • 12. Invited commentary.
    Shander A, Javidroozi M.
    Ann Thorac Surg; 2008 Mar 01; 85(3):844. PubMed ID: 18291153
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery.
    Tanaka KA, Mazzeffi MA, Grube M, Ogawa S, Chen EP.
    Transfusion; 2013 Apr 01; 53(4):920-1. PubMed ID: 23565996
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.
    Mazer CD, Leong-Poi H, Mahoney J, Latter D, Strauss BH, Teitel JM.
    Semin Cardiothorac Vasc Anesth; 2007 Dec 01; 11(4):261-4. PubMed ID: 18270189
    [Abstract] [Full Text] [Related]

  • 19. Protocolized hemostatic factor use in major thoracic aortic surgery.
    Wagner MA, Wang H, Benrashid E, Keenan JE, Krishnamurthy Y, Levy JH, Welsby IJ, Hughes GC.
    J Cardiovasc Surg (Torino); 2019 Oct 01; 60(5):633-636. PubMed ID: 31302952
    [No Abstract] [Full Text] [Related]

  • 20. Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage.
    Lamarche Y, Demers P, Poirier NC, Robitaille D, Cartier R.
    Can J Cardiol; 2007 Aug 01; 23(10):809-13. PubMed ID: 17703260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.